MBS China Healthcare Club - China Pharma Market Overview and Outlook
11th December 2015, Ms. Lisa Sun, one of MBS alumni holding an MBA Degree from UK, now Sales Director at IMS Health, shared her predictions about medical and technological trends, prospects and commercial opportunities in China pharmaceutical industry with GMBA students and alumni. Lisa demonstrated her outlook for the Chinese pharma market with the audience on trends, companies and potentials of the industry.
Lisa is Sales Director based in IMS Shanghai office, her team mainly serves domestic pharma clients and medical device clients since 2015. She has over 16 years healthcare consulting experience in pharmaceutical, consumer health and medical device field, and her experience covered broad business issues such as product/brand positioning, market access, distribution and operation, commercial effectiveness, etc.
Lisa took many key roles in different teams since joined IMS in 2007, she has about 8 years to work with many leading MNC clients before her current role. Key clients include Roche, Eli Lilly, Bayer CHC, MSD , Pfizer, Sanofi CHC, Johnson & Johnson, Abbott, etc. Through IMS data offerings, market research and consulting services, she assists her clients to achieve their business success.